Clinical Trial Update: Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer [Phase 3]

View source ↗

Summary

Expanded access trial update for diagnostic imaging in staging recurrent metastatic prostate cancer; Phase 3 completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Global Isotopes, LLC d/b/a Zevacor Molecular | Conditions: Metastatic Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2019-12-17